PRZOOM - /newswire/ -
Wood Dale, IL, United States, 2011/07/07 - SANYO and BD Biosciences, a segment of BD, announced a strategic agreement today to jointly promote cutting-edge life science research tools designed to advance cell culture and cell therapy research. NYSE: BDX
SANYO North America Corporation (SANYO) Biomedical Solutions Division and BD Biosciences, a segment of BD (Becton, Dickinson and Company), announced a strategic agreement today to jointly promote cutting-edge life science research tools designed to advance cell culture and cell therapy research, which will help them expand their presence in the cell therapy, cell culture and overall life sciences markets.
“Leveraging our collective strengths, SANYO and BD Biosciences aim to continually advance products that help research and development,” said SANYO Biomedical Solutions division President Toshiaki Inoue. “This collaboration will enable us to offer our customers more value by integrating our existing products and technologies as well as exploring new cell therapy research tools.”
The goals of this collaboration are to develop long-term and short-term co-marketing programs, as well as to research innovative ways to combine product technologies and offerings to serve both current and untapped market applications. SANYO will integrate with BD Biosciences’ SySTEMatic ExCELLenceSMmarketing campaign.
“This collaboration reflects BD Biosciences’ commitment to delivering best-in-class, highly integrated products and services to help life scientists reduce risk and ensure superior quality, while producing clinical-grade stem cell applications,” said Bill Rhodes, President, BD Biosciences.
The two businesses will work together to grow current and future business by combining SANYO CO2 incubators with specialized BD Biosciences - Discovery Labware products. They will also combine SANYO refrigerators and freezers with BD Advanced Bioprocessing cell culture media and supplements for multiple research applications.
BD (bd.com), a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public.
SANYO Electric Co., Ltd (us.sanyo.com) is a global, leading provider of energy, environment, and lifestyle applications.Biomedical Solutions, a Divisionof SANYO North America Corporation (a subsidiary of SANYO Electric Co., Ltd.), is based in Wood Dale, IL, and provides laboratory equipment for pharmaceutical, life science and biotechnology applications. Product lines include space-efficient VIP® ultra-low temperature freezers, cryogenic freezers, pharmaceutical and medical refrigerators, cell culture incubators, plant growth chambers, and portable autoclaves.
Aaron Fowles - SANYO Manager, Corporate Communications
P: (619) 661-4151 / E: E: afowles[.]sna.sanyo.com.